Israel · Delayed Price · Currency is ILS · Price in ILA Epitomee Medical Statistics
Total Valuation
TLV:EPIT has a market cap or net worth of ILS 235.51 million. The enterprise value is 189.06 million.
| Market Cap | 235.51M |
| Enterprise Value | 189.06M |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TLV:EPIT has 29.81 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | 29.81M |
| Shares Outstanding | 29.81M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 37.65% |
| Owned by Institutions (%) | 12.67% |
| Float | 13.00M |
Valuation Ratios
The trailing PE ratio is 213.71.
| PE Ratio | 213.71 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 171.60 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.44 |
Financial Position
The company has a current ratio of 7.72, with a Debt / Equity ratio of 0.15.
| Current Ratio | 7.72 |
| Quick Ratio | 7.62 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.36 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.08% and return on invested capital (ROIC) is -3.18%.
| Return on Equity (ROE) | 1.08% |
| Return on Assets (ROA) | -3.04% |
| Return on Invested Capital (ROIC) | -3.18% |
| Return on Capital Employed (ROCE) | -5.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 26,232 |
| Employee Count | 42 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +154.20% in the last 52 weeks. The beta is 0.76, so TLV:EPIT's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | +154.20% |
| 50-Day Moving Average | 857.40 |
| 200-Day Moving Average | 901.67 |
| Relative Strength Index (RSI) | 40.59 |
| Average Volume (20 Days) | 12,527 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.94M |
| Pretax Income | 1.10M |
| Net Income | 1.10M |
| EBITDA | -3.68M |
| EBIT | -5.94M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 61.58 million in cash and 15.13 million in debt, giving a net cash position of 46.45 million or 1.56 per share.
| Cash & Cash Equivalents | 61.58M |
| Total Debt | 15.13M |
| Net Cash | 46.45M |
| Net Cash Per Share | 1.56 |
| Equity (Book Value) | 103.49M |
| Book Value Per Share | 3.47 |
| Working Capital | 55.22M |
Cash Flow
In the last 12 months, operating cash flow was -26.47 million and capital expenditures -16.12 million, giving a free cash flow of -42.58 million.
| Operating Cash Flow | -26.47M |
| Capital Expenditures | -16.12M |
| Free Cash Flow | -42.58M |
| FCF Per Share | -1.43 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TLV:EPIT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.47% |
| FCF Yield | -18.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |